Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic Syndromes

NCT00045305 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

17

Enrollment

NETWORK

Sponsor class

Conditions

Leukemia
Myelodysplastic Syndromes
Myelodysplastic/Myeloproliferative Neoplasms

Interventions

DRUG: Cyclosporine
DRUG: Methotrexate
DRUG: Photopheresis
DRUG: Mycofenolate mofetil
DRUG: Pentostatin
PROCEDURE: allogeneic bone marrow
PROCEDURE: peripheral blood stem cell
RADIATION: Total body irradiation

Sponsor

Eastern Cooperative Oncology Group

Collaborators

[object Object]